Stock Analysis

3 Stocks Including BHI That May Be Trading Below Fair Value Estimates

Published

In recent weeks, global markets have experienced volatility, with U.S. stocks ending lower amid tariff uncertainties and mixed economic data suggesting a cooling labor market and fluctuating manufacturing activity. Despite these challenges, certain stocks may present opportunities for investors by trading below their fair value estimates, making them potentially attractive options in the current economic landscape.

Top 10 Undervalued Stocks Based On Cash Flows

NameCurrent PriceFair Value (Est)Discount (Est)
Tibet Rhodiola Pharmaceutical Holding (SHSE:600211)CN¥36.50CN¥72.7549.8%
Atour Lifestyle Holdings (NasdaqGS:ATAT)US$29.57US$58.9449.8%
Biotage (OM:BIOT)SEK138.70SEK273.6149.3%
Nuvoton Technology (TWSE:4919)NT$95.90NT$191.6049.9%
Saigon Thuong Tin Commercial Bank (HOSE:STB)₫38250.00₫76325.1449.9%
Canatu Oyj (HLSE:CANATU)€12.50€24.7949.6%
RENK Group (DB:R3NK)€24.94€49.3749.5%
TLB (KOSDAQ:A356860)₩18560.00₩36677.3049.4%
Marcus & Millichap (NYSE:MMI)US$37.27US$73.7649.5%
Kyndryl Holdings (NYSE:KD)US$41.54US$82.1449.4%

Click here to see the full list of 910 stocks from our Undervalued Stocks Based On Cash Flows screener.

Here's a peek at a few of the choices from the screener.

BHI (KOSDAQ:A083650)

Overview: BHI Co., Ltd. is involved in the development, manufacture, and supply of power plant equipment globally with a market cap of ₩690 billion.

Operations: BHI Co., Ltd. generates revenue through its global operations focused on the development, manufacture, and supply of equipment for power plants.

Estimated Discount To Fair Value: 12.3%

BHI is trading at ₩23,000, about 12.3% below its estimated fair value of ₩26,235.14, suggesting potential undervaluation based on cash flows. Earnings are forecast to grow significantly at 29.5% annually over the next three years, outpacing the KR market's growth rate of 26%. However, interest payments are not well covered by earnings and share price volatility has been high recently. Recent special calls aim to enhance corporate understanding and value.

KOSDAQ:A083650 Discounted Cash Flow as at Feb 2025

Neosem (KOSDAQ:A253590)

Overview: Neosem Inc. manufactures and sells semiconductor inspection equipment, with a market cap of ₩426.69 billion.

Operations: The company generates revenue from its Semiconductor Equipment and Services segment, totaling ₩96.47 billion.

Estimated Discount To Fair Value: 48%

Neosem, trading at ₩12,440, is significantly undervalued based on cash flows with a fair value estimate of ₩23,929.71. The stock's revenue and earnings are expected to grow substantially at 32.9% and 61.7% annually over the next three years, surpassing the KR market averages of 8.8% and 26%, respectively. Despite recent profit growth of 19.7%, Neosem's strong forecasted performance highlights its potential as an undervalued investment opportunity in the current market landscape.

KOSDAQ:A253590 Discounted Cash Flow as at Feb 2025

Chongqing Baiya Sanitary Products (SZSE:003006)

Overview: Chongqing Baiya Sanitary Products Co., Ltd. operates in the hygiene sector, producing sanitary products, with a market cap of CN¥10.14 billion.

Operations: The company's revenue from personal products amounts to CN¥3.25 billion.

Estimated Discount To Fair Value: 24.9%

Chongqing Baiya Sanitary Products is trading at CN¥23.8, significantly undervalued with a fair value estimate of CN¥31.68. The company's revenue and earnings are forecast to grow robustly at 21.9% and 28.65% annually, outpacing the Chinese market averages of 13.4% and 25.3%. Despite its dividend being inadequately covered by free cash flows, recent earnings growth supports its potential as an attractive investment based on cash flow valuation metrics.

SZSE:003006 Discounted Cash Flow as at Feb 2025

Turning Ideas Into Actions

Seeking Other Investments?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com